Biogen Inc.
BIIB
$131.95
$3.953.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.82% | -0.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.82% | -0.97% | |||
| Cost of Revenue | -4.40% | -0.96% | |||
| Gross Profit | 12.95% | -0.97% | |||
| SG&A Expenses | 1.17% | -15.34% | |||
| Depreciation & Amortization | 13.95% | 22.86% | |||
| Other Operating Expenses | 29.09% | 1.75% | |||
| Total Operating Expenses | -1.10% | -9.22% | |||
| Operating Income | 34.27% | 29.17% | |||
| Income Before Tax | 139.07% | 6.76% | |||
| Income Tax Expenses | 54.46% | 185.08% | |||
| Earnings from Continuing Operations | 163.95% | -9.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 163.95% | -9.82% | |||
| EBIT | 34.27% | 29.17% | |||
| EBITDA | 28.30% | 21.52% | |||
| EPS Basic | 163.23% | -10.07% | |||
| Normalized Basic EPS | 32.38% | 18.15% | |||
| EPS Diluted | 164.02% | -9.94% | |||
| Normalized Diluted EPS | 32.65% | 18.06% | |||
| Average Basic Shares Outstanding | 0.27% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||